_:na7ba71b7f24f4a59957b4d1ff79c88d6xb0
<http://schema.org/description>
"Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center will present a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma (mRCC) at the ASCO Annual Meeting on June 3, 2013."
<https://medicalxpress.com/news/2013-06-safety-nivolumab-kidney-cancer.html>